Organization: Trillium Therapeutics Inc

Trillium Therapeutics acquires Australia’s Arthron

Trillium Therapeutics Inc, Toronto, has acquired Arthron Ltd Pty, a subsidiary of Prima Biomed Ltd, Melbourne Australia. Trillium will provide Prima with an upfront cash payment and shares representing 5.6% of its outstanding share capital. Prima will also be eligible to receive additional shares if certain business development and clinical milestones are met. Arthron owns…

Trillium Therapeutics signs pact with Genentech

Trillium Therapeutics Inc has entered into an agreement with biotech giant Genentech Inc, San Francisco, to develop and commercialize its technology in the area of protein therapeutics. The exact nature of the technology and the terms of the agreement were not disclosed. The agreement will provide privately held Trillium with an upfront payment, research funding…